Applicability of Subheading 9817.00.96, HTSUS to CMORE CT System
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The CMORE CT System at issue is eligible for duty-free treatment under subheading 9817.00.96, HTSUS, as articles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons. 4 Duty rates are provided for your convenience and are subject to change.
Ruling text
This is in response to your request, on behalf of icotec AG, dated September 12, 2025, for a binding ruling regarding the eligibility of the CMORE CT System for subheading 9817.00.96, Harmonized Tariff Schedule of the United States (“HTSUS”), treatment. Our ruling is set forth below. FACTS: icotec AG is an FDA-registered Swiss company that specializes in the development and distribution of spinal implant systems. The imported merchandise concerns icotec AG’s CMORE CT (cervico-thoracic) System.
The CMORE CT System is permanently implanted into patients by surgeons to provide posterior stabilization of the upper spine. The CMORE CT system consists of polyaxial solid screws made of icotec AG’s proprietary BlackArmor® carbon-fiber reinforced polyetheretherketone (Carbon/PEEK) material, with embedded tantalum markers in the tip and head of each screw. The screws are embedded in the upper spine and linked with connectors to rods, both of which are composed of BlackArmor® Carbon/PEEK.
Once assembled, the CMORE CT System creates an internal framework that immobilizes and stabilizes the cervical and upper thoracic spine. icotec AG maintains that without such surgical stabilization, those affected face risks such as losing the ability to stand, walk, or sit upright.
Additionally, they may face permanent neurological damage, spinal deformity, and life- threatening complications from sepsis or respiratory failure from a collapsed spinal structure. icotec AG submits that the CMORE CT System is used for patients with the following 1 medical conditions: (1) advanced stage tumors involving the cervical spine in whom life expectancy prior to treatment is of insufficient duration to permit spinal fusion; (2) traumatic spinal fractures and/or dislocations; (3) spinal instability or deformity; (4) failed previous fusions (e.g., pseudoarthrosis); (5) degenerative disease, including intractable radiculopathy and/or myelopathy; (6) neck and/or arm pain of discogenic origin as confirmed by radiographic studies; (7) degenerative disease of the facets with instability; and (8) patients with spinal infections (e.g., spondylodiscitis, osteomyelitis) and spinal instability due to infection, surgical debridement, or decompression. icotec AG states that the CMORE CT System is designed to restore patients’ spinal stability who suffer from these conditions.
The CMORE CT System includes the following parts, which come in varying sizes to conform to a patient’s spine: nuts and nut screws, cross links, straight and curved rods, polyaxial and shank screws, and axial and parallel connectors, which are composed of BlackArmor® Carbon/PEEK or titanium alloy.
All parts for the CMORE CT System are manufactured by icotec AG solely for use with the CMORE CT System and must meet precise specifications and sterility requirements as articles to be implanted permanently in the human body. icotec AG states that there is no other use for the CMORE CT System besides the uses noted above and the CMORE CT System may only be ordered by a prescribing physician and installed by a surgeon.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (H353889).